Nuritas is a company revolutionising the discovery of natural active ingredients, using artificial intelligence with DNA analysis to data-mine billions of molecules, in what they call a ‘disruptive approach to discovery’. Naturally, the ‘revolutionising’ part caught our eye, so we spoke to Neil Foster, Head of Strategic Partnerships at Nuritas, to enthuse about artificial intelligence and the reason they’re hunting for peptides in the first place.

Nuritas is a company revolutionising the discovery of natural active ingredients, using artificial intelligence with DNA analysis to data-mine billions of molecules, in what they call a ‘disruptive approach to discovery’. Naturally, the ‘revolutionising’ part caught our eye, so we spoke to Neil Foster, Head of Strategic Partnerships at Nuritas, to enthuse about artificial intelligence and the reason they’re hunting for peptides in the first place.

Nuritas is a company revolutionising the discovery of natural active ingredients, using artificial intelligence with DNA analysis to data-mine billions of molecules, in what they call a ‘disruptive approach to discovery’. Naturally, the ‘revolutionising’ part caught our eye, so we spoke to Neil Foster, Head of Strategic Partnerships at Nuritas, to enthuse about artificial intelligence and the reason they’re hunting for peptides in the first place.

The current new dietary ingredient (NDI) draft guidance will be finalized before the end of the year with no modifications, accord to Brian Frisby, general manager, KGK Compliance Advisors, who said he has sources inside FDA. In this podcast, Frisby discusses the NDI enforcement and notification best practices with Sandy Almendarez, editor in chief, INSIDER

The current new dietary ingredient (NDI) draft guidance will be finalized before the end of the year with no modifications, accord to Brian Frisby, general manager, KGK Compliance Advisors, who said he has sources inside FDA. In this podcast, Frisby discusses the NDI enforcement and notification best practices with Sandy Almendarez, editor in chief, INSIDER

The current new dietary ingredient (NDI) draft guidance will be finalized before the end of the year with no modifications, accord to Brian Frisby, general manager, KGK Compliance Advisors, who said he has sources inside FDA. In this podcast, Frisby discusses the NDI enforcement and notification best practices with Sandy Almendarez, editor in chief, INSIDER

Live from Vitafoods Europe 2017, Vitafoods Insights met with Prof Philip Calder from the University of Southampton after his session in the Omega-3 Forum, one of the R&D forums from this year’s Education Programme. He spoke about omega-3 fatty acids and their biological effects, so was the perfect person for Jade Mitchell-Ross to sit down with and discuss omega-3s and their seemingly endless health benefits. You can learn more about omega-3s on our website, vitafoodsinsights.com, where you can download the January edition of our Digital Magazine, The Widespread Appeal of Omega-3s.

Live from Vitafoods Europe 2017, Vitafoods Insights met with Prof Philip Calder from the University of Southampton after his session in the Omega-3 Forum, one of the R&D forums from this year’s Education Programme. He spoke about omega-3 fatty acids and their biological effects, so was the perfect person for Jade Mitchell-Ross to sit down with and discuss omega-3s and their seemingly endless health benefits. You can learn more about omega-3s on our website, vitafoodsinsights.com, where you can download the January edition of our Digital Magazine, The Widespread Appeal of Omega-3s.

The preamble to the dietary supplement cGMPs (current good manufacturing practices) is an often-overlooked resource that help businesses that manufacturer, package, label or hold supplements in the United States. As Dr. Tara Lin Couch, EAS independent advisor, dietary supplements, noted in this podcast with Sandy Almendarez, editor in chief, INSIDER, this preamble is FDA’s guide to what it’s thinking on specific GMP requirements. Couch and Almendarez further dive into supplement GMPs.

The preamble to the dietary supplement cGMPs (current good manufacturing practices) is an often-overlooked resource that help businesses that manufacturer, package, label or hold supplements in the United States. As Dr. Tara Lin Couch, EAS independent advisor, dietary supplements, noted in this podcast with Sandy Almendarez, editor in chief, INSIDER, this preamble is FDA’s guide to what it’s thinking on specific GMP requirements. Couch and Almendarez further dive into supplement GMPs.